Consequently, we developed a multi-indicator model to screen for NAFLD screening in overweight or obese patients with PCOS using readily available anthropometric and laboratory parameters such as triglycerides, LDL-C, glucose, insulin, and SHBG levels. Here, SHBG is linked to metabolic dysfunction-associated steatotic liver disease.